Lista de obras - Anna Korycka-Wołowiec - Dominio Público Uruguay

Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study ⬇️

artículo científico publicado el 1 de enero de 2012

Bendamustine alone or with rituximab modifies expression of apoptosis-regulating genes and proteins of CLL cells, depending on IGVH mutational status

artículo científico publicado en 2018

Changes in the apoptotic gene expression profile in CLL patients treated with rituximab combined with cladribine and cyclophosphamide-preliminary results

article

Chromosomal aberrations in chronic lymphocytic leukemia detected by conventional cytogenetics with DSP30 as a single agent: comparison with FISH

artículo científico publicado en 2011

Chronic myelomonocytic leukemia coexisting with B-cell chronic lymphocytic leukemia

artículo científico publicado en 2003

Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity

artículo científico publicado en 2009

Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance.

artículo científico publicado en 2013

Coexistence of chronic lymphocytic leukemia and essential thrombocythemia

artículo científico publicado en 2003

Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients

artículo científico publicado en 2013

Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.

artículo científico publicado en 2009

Cytotoxic and apoptosis-inducing effects of bendamustine used alone and in combination with rituximab on chronic lymphocytic leukemia cells in vitro

scientific article published on 05 December 2014

Depsipeptide (FK228) as a novel histone deacetylase inhibitor: mechanism of action and anticancer activity

artículo científico publicado en 2007

Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction

artículo científico publicado en 2009

Forodesine (BCX-1777, Immucillin H)--a new purine nucleoside analogue: mechanism of action and potential clinical application

artículo científico publicado en 2007

Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide.

artículo científico publicado en 2003

Impact of intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction on left ventricular perfusion and function: a 6-month follow-up gated 99mTc-MIBI single-photon emission computed tomography study

artículo científico publicado en 2008

New insights into biology, prognostic factors, and current therapeutic strategies in chronic lymphocytic leukemia

artículo científico publicado en 2013

Novel purine nucleoside analogues for hematological malignancies

artículo científico publicado en 2008

Ofatumumab for treating chronic lymphocytic leukemia: a safety profile

artículo científico publicado en 2015

Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies

artículo científico publicado en 2006

Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly

artículo científico

Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies ⬇️

artículo científico publicado el 13 de septiembre de 2012

Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity

artículo científico publicado en 2006

The Influence of Imatinib Mesylate (STI571) used alone or in Combination with Purine Nucleoside Analogues on the Normal and Chronic Myelogenous Leukaemia Progenitor CellsIn Vitro ⬇️

artículo científico publicado el 1 de septiembre de 2003

The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.

artículo científico publicado en 2003

The effects of intracoronary autologous mononuclear bone marrow cell transplantation on cardiac arrhythmia and heart rate variability

artículo científico publicado en 2009

The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results.

artículo científico publicado en 2011

The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro

artículo científico publicado en 2004

The safety of available chemo-free treatments for mantle cell lymphoma

scientific article published on 18 September 2020

The safety profile of monoclonal antibodies for chronic lymphocytic leukemia

artículo científico publicado en 2016

Type of serum influences the rituximab dependent cytotoxicity and apoptosis of chronic lymphocytic leukemia cells in vitro

artículo científico publicado en 2012

Venetoclax in the treatment of chronic lymphocytic leukemia

artículo científico publicado en 2019

Lista de obras de Anna Korycka-Wołowiec

Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study ⬇️

Bendamustine alone or with rituximab modifies expression of apoptosis-regulating genes and proteins of CLL cells, depending on IGVH mutational status

Changes in the apoptotic gene expression profile in CLL patients treated with rituximab combined with cladribine and cyclophosphamide-preliminary results

Chromosomal aberrations in chronic lymphocytic leukemia detected by conventional cytogenetics with DSP30 as a single agent: comparison with FISH

Chronic myelomonocytic leukemia coexisting with B-cell chronic lymphocytic leukemia

Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity

Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance.

Coexistence of chronic lymphocytic leukemia and essential thrombocythemia

Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients

Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.

Cytotoxic and apoptosis-inducing effects of bendamustine used alone and in combination with rituximab on chronic lymphocytic leukemia cells in vitro

Depsipeptide (FK228) as a novel histone deacetylase inhibitor: mechanism of action and anticancer activity

Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction

Forodesine (BCX-1777, Immucillin H)--a new purine nucleoside analogue: mechanism of action and potential clinical application

Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide.

Impact of intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction on left ventricular perfusion and function: a 6-month follow-up gated 99mTc-MIBI single-photon emission computed tomography study

New insights into biology, prognostic factors, and current therapeutic strategies in chronic lymphocytic leukemia

Novel purine nucleoside analogues for hematological malignancies

Ofatumumab for treating chronic lymphocytic leukemia: a safety profile

Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies

Pharmacodynamic considerations of small molecule targeted therapy for treating B-cell malignancies in the elderly

Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies ⬇️

Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity

The Influence of Imatinib Mesylate (STI571) used alone or in Combination with Purine Nucleoside Analogues on the Normal and Chronic Myelogenous Leukaemia Progenitor CellsIn Vitro ⬇️

The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.

The effects of intracoronary autologous mononuclear bone marrow cell transplantation on cardiac arrhythmia and heart rate variability

The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results.

The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro

The safety of available chemo-free treatments for mantle cell lymphoma

The safety profile of monoclonal antibodies for chronic lymphocytic leukemia

Type of serum influences the rituximab dependent cytotoxicity and apoptosis of chronic lymphocytic leukemia cells in vitro

Venetoclax in the treatment of chronic lymphocytic leukemia

Wpływ skojarzonego działania bendamustyny i rytuksymabu na apoptozę i nekrozę komórek przewlekłej białaczki limfocytowej w hodowli in vitro